<?xml version="1.0" encoding="UTF-8"?>
<ref id="R50">
 <label>50</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Fetter</surname>
    <given-names>T</given-names>
   </string-name>, 
   <string-name>
    <surname>Smith</surname>
    <given-names>P</given-names>
   </string-name>, 
   <string-name>
    <surname>Guel</surname>
    <given-names>T</given-names>
   </string-name>, 
   <etal>et al</etal>
  </person-group>. 
  <article-title>Selective janus kinase 1 inhibition is a promising therapeutic approach for lupus erythematosus skin lesions</article-title>. 
  <source>Front Immunol</source>
  <year>2020</year>;
  <volume>11</volume>:
  <elocation-id>344</elocation-id>. 
  <pub-id pub-id-type="doi">10.3389/fimmu.2020.00344</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/32194562?>
  <pub-id pub-id-type="pmid">32194562</pub-id>
 </mixed-citation>
</ref>
